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ABSTRACT
Background: Studies of the role of dietary factors in epithelial ovar-
ian cancer (EOC) development have been limited, and no specific
dietary factors have been consistently associated with EOC risk.
Objective: We used a nutrient-wide association study approach to
systematically test the association between dietary factors and invasive
EOC risk while accounting for multiple hypothesis testing by using the
false discovery rate and evaluated the findings in an independent cohort.
Design: We assessed dietary intake amounts of 28 foods/food groups
and 29 nutrients estimated by using dietary questionnaires in the EPIC
(European Prospective Investigation into Cancer and Nutrition) study
(n = 1095 cases). We selected 4 foods/nutrients that were statistically
significantly associated with EOC risk when comparing the extreme
quartiles of intake in the EPIC study (false discovery rate = 0.43) and
evaluated these factors in the NLCS (Netherlands Cohort Study; n =
383 cases). Cox regression models were used to estimate HRs and
95% CIs.
Results: None of the 4 dietary factors that were associated with EOC
risk in the EPIC study (cholesterol, polyunsaturated and saturated fat,
and bananas) were statistically significantly associated with EOC risk
in the NLCS; however, in meta-analysis of the EPIC study and the
NLCS, we observed a higher risk of EOC with a high than with a low
intake of saturated fat (quartile 4 compared with quartile 1; overall HR:
1.21; 95% CI: 1.04, 1.41).
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Conclusion: In the meta-analysis of both studies, there was a higher
risk of EOC with a high than with a low intake of saturated fat.
Am J Clin Nutr 2016;103:161–7.
Keywords: nutrition, ovarian cancer, saturated fat, serous, pro-
spective cohort, diet
INTRODUCTION
Diet is an important modifiable factor that has been shown to
influence cancer risk in general (1); however, it is uncertain
whether dietary factors may be useful for the prevention of
epithelial ovarian cancer (EOC).48 The identification of modi-
fiable dietary factors for the primary prevention of EOC is im-
portant because there are currently no strategies for early
detection, and consequently most patients are diagnosed with
advanced-stage disease that has a low 5-y survival rate (40% in
Europe) (2).
A systematic meta-analysis by the World Cancer Research
Fund (3) and a systematic literature review (4) focusing on
dietary factors and EOC risk in prospective cohort studies
observed that the current evidence was too limited, and no
specific dietary factors were consistently associated with EOC
risk. Inconsistent results across studies of dietary factors and
EOC risk may be due to insufficient sample sizes and/or dietary
measurement error (4) or the possibility that there may be no
effect.
To systematically evaluate the role of dietary factors in relation
to EOC risk, we used a nutrient-wide association study (NWAS)
that is similar to methods that are routinely used in genetics
studies; this involved the assessment of an extensive list of
foods/food groups and nutrients in relation to EOC risk while
accounting for multiple testing by estimating the false discovery
rate (FDR) (5), followed by the evaluation of the statistically
significant results in an independent study. The NWAS method
has been used to identify novel dietary risk associations for
diabetes and blood pressure (6, 7). We recently conducted a
NWAS of endometrial cancer that involved the investigation of
foods/nutrients in the EPIC (European Prospective Investigation
into Cancer and Nutrition) study, estimation of the FDR, and
confirmation of selected study findings in the Nurses’ Health
Study and the Nurses’ Health Study II and observed that most
dietary factors were not associated with endometrial cancer risk;
however, we highlighted an inverse association between coffee
intake and endometrial cancer risk (8). The current study de-
scribes the use of the NWAS approach to evaluate an extensive
list of dietary factors in relation to EOC risk in 2 prospective
European cohort studies.
METHODS
This NWAS involved the investigation of intakes of 28 foods/
food groups and 29 nutrients in relation to risk of EOC in the
EPIC study, identification of statistically significant associations
when comparing participants who were classified in quartile 4
with those in quartile 1 of dietary intake amounts, estimation of
the associated FDR, and investigation of selected dietary factors
in an independent validation cohort, the NLCS (Netherlands
Cohort Study). To compute the overall effect estimates for the
selected foods/nutrients in relation to EOC risk, we used a random-
effects meta-analytic method (Supplemental Figure 1). The cur-
rent study focused on EOC because there are no consistent dietary
associations; therefore, the NWAS approach may be particularly
useful because it involves the systematic investigation and report-
ing of risk associations for a range of foods/nutrients in relation to
EOC risk.
Study populations
The EPIC study includes 521,330 male and female participants
aged 25–70 y at enrollment (1991–2000) (9). From 367,903
women in the EPIC study, individuals were excluded if they
reported a prevalent cancer except nonmelanoma skin cancer
(n = 19,853), were missing follow-up information (n = 2898),
had a bilateral oophorectomy (n = 10,404), did not complete
a dietary questionnaire (n = 3217), were classified in the top or
bottom 1% of energy intake to energy requirement (n = 6502)
(to reduce the effect of implausible extreme values on the
analysis), were missing a lifestyle questionnaire (n = 22), or had
outlying values for specific nutrient intakes (n = 3); 325,004
participants remained in the current study. Informed consent was
provided by all participants, and ethical approval for the study
was obtained from the internal review board of the International
Agency for Research on Cancer and from local ethics commit-
tees in each participating country.
Incident ovarian cancers in the EPIC study were identified
through population-based cancer registries or active follow-up,
and mortality data were obtained from cancer or mortality reg-
istries (9). Ovarian cancers were classified as ovarian, fallopian
1The coordination of the EPIC study is supported by the European Com-
mission [Directorate-General for Health and Consumers (DG-SANCO)] and
the International Agency for Research on Cancer for the coordination of the
European Prospective Investigation into Cancer and Nutrition study. The na-
tional cohorts are supported by Danish Cancer Society (Denmark); Ligue
Contre le Cancer, Institut Gustave Roussy, Mutuelle Générale de l’Education
Nationale, and Institut National de la Santé et de la Recherche Médicale
(Inserm) (France); Deutsche Krebshilfe, Deutsches Krebsforschungszen-
trum, and Federal Ministry of Education and Research (Germany); the
Hellenic Health Foundation (Greece); Associazione Italiana per la Ri-
cerca sul Cancro (AIRC) Italy and National Research Council (Italy);
Dutch Ministry of Public Health, Welfare and Sports (VWS), Nether-
lands Cancer Registry (NKR), LK Research Funds, Dutch Prevention
Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Re-
search Fund, and Statistics Netherlands (Netherlands); Health Research
Fund [Fund for Health of Spain (FIS)], Regional Governments of Anda-
lucía, Asturias, Basque Country, Murcia (no. 6236) and Navarra, Insti-
tuto de Salud Carlos III (ISCIII) Redes Temáticas de Investigación
Cooperativa (RETIC) (RD06/0020) (Spain); Swedish Cancer Society,
Swedish Research Council, and County Councils of Skåne and Västerbotten
(Sweden); and Cancer Research UK (14136 to NW and KTK; C570/A16491
and C8221/A19170 to RCT) and Medical Research Council (1000143 to NW
and KTK; MR/M012190/1 to RCT) (United Kingdom). The Netherlands Co-
hort Study was supported by the Dutch Cancer Society and World Cancer
Research Fund. CJP has received funding from the NIH (K99 ES023504) and
PhRMA Foundation.
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tube, and primary peritoneal cancers based on the third revision
of the International Classification of Diseases for Oncology codes
C56.9, C57.0 and C48, respectively. From 325,004 study par-
ticipants, 1293 first-incident ovarian cancer cases were identified,
and cases were censored if they were nonepithelial (n = 77),
missing tumor behavior (n = 25), or tumors of borderline ma-
lignancy (n = 96); 1095 invasive EOCs were evaluated in the
current study.
The NLCS was established in September 1986 and includes
62,573 women from the general population, aged 55–69 y, who
resided in 204 municipalities with computerized population
registries (10). At the start of the study, participants completed
a self-administered questionnaire on diet, lifestyle factors,
medical histories, and other putative cancer risk factors. A case-
cohort approach was used for reasons of efficiency in ques-
tionnaire processing and follow-up. Cancer cases were identified
from the entire cohort, whereas the accumulated person-years
of the entire cohort were calculated from a random subcohort
of 2589 women who were selected immediately after baseline.
Information about new cancer diagnoses was collected annually
by using record linkage to the Netherlands cancer registry and
a pathology registry. For cases and subcohort members, we
excluded participants with a prevalent cancer other than non-
melanoma skin cancer at baseline (n = 52) and women who
reported an oophorectomy (n = 33). After a maximum follow-up
of 17.3 y, 427 incident, invasive EOCs were identified. Partici-
pants with incomplete or inconsistent dietary data (11) were also
excluded (n = 227 total; 44 cases, including one case who was
a subcohort member, and 183 noncase subcohort members); this
left 383 invasive EOC cases (including 17 cases who were
subcohort members) and 2199 noncase subcohort members in
the current analysis. The NLCS was approved by the institutional
review boards of the Nederlandse Organisatie voor Toegepast
Natuurwetenschappelijk Onderzoek (TNO) Quality of Life re-
search institute (Zeist, Netherlands) and Maastricht University
(Maastricht, Netherlands).
Dietary assessment
The habitual diet of the EPIC participants at enrollment was
assessed by using country-specific or study center-specific di-
etary questionnaires or food records (9), and for this study, we
evaluated foods/food groups and nutrients that were available
in all 10 countries. The country and center-specific dietary
questionnaires have been validated mostly by using monthly
24-h recall interviews (12). The EPIC Nutrient Database was used
to calculate standardized nutrient intake for the 10 countries,
and all standardized priority nutrients were analyzed; nutri-
ents were prioritized according to their availability in national
databases for countries participating in the EPIC study, their
relative comparability, completeness, and relevance to cancer
etiology (13).
The NLCS participants completed a 150-item semiquantitative
food-frequency questionnaire at baseline that estimated the mean
frequency and amounts of foods and beverages consumed in the
previous 12 mo. The food-frequency questionnaire has been
validated and tested for reproducibility (11, 14). Nutrient intakes
were calculated by multiplying the frequency of intake by the
nutrient content of specified portions based on the Dutch food
composition table (15).
Measurement of other covariates
The following covariates were selected a priori and were
adjusted for in all multivariate models: total energy intake (kcal,
continuous) and established risk factors of EOC, oral contra-
ceptive use [never use (reference), use ,5 y, use 5+ y, ever use
(unknown duration), missing], menopausal status [premenopausal
(reference), postmenopausal, dubious or unknown menopause],
and the number of full-term pregnancies [0 (reference), 1–2, 3–4,
.4, parous (unknown number), missing]. In the EPIC study, we
further adjusted the multivariate models for BMI, physical ac-
tivity, smoking status, and educational attainment, and the risk
estimates were very similar and therefore these covariates were
not included in the final models. All models were stratified by the
participant’s age at recruitment (continuous) and the study center
(EPIC only).
Statistical methods
Individual foods/food groups and nutrients were related one at
a time to the risk of EOC by using Cox proportional hazards
regression to estimate the HRs and 95% CIs. In the EPIC study,
age was the underlying time metric for Cox regression, with the
subjects’ age at recruitment as the entry time and their age at
cancer diagnosis, death, emigration, or last follow-up, whichever
occurred first, as the exit time. Dietary factors were modeled in
all of the EPIC countries together, and to control for differing
follow-up procedures, questionnaire design, and other differ-
ences across study centers, we stratified all models by study
center as well as the age at recruitment (continuous).
In the NLCS, the total person-years at risk were estimated from
the subcohort, and Prentice-weighted Cox proportional hazards
regression models for case-cohort designs with robust SE esti-
mates (16) were used to estimate HRs and 95% CIs. In both
studies, the proportional hazards assumption was verified by
using the method described by Grambsch and Therneau (17).
Nutrient intakes were energy adjusted by using the regression
residual method (18) separately for the entire EPIC cohort and the
NLCS, and participants were classified into quartiles of con-
sumption unless stated otherwise. In the EPIC study, dietary
intake amounts were divided into quartiles based on the distri-
bution in the entire cohort, and in the NLCS, quartiles were based
on the subcohort set. The P value for the test of linear trend was
calculated by modeling a continuous term. To test for hetero-
geneity between countries in the EPIC study, we conducted data
analyses separately within each country and pooled them by
using a random-effects meta-analytic method with the restricted
maximum likelihood estimator (19).
To account for multiple comparisons in the EPIC study, we
estimated the FDR for each food/nutrient, which is the ratio of the
expected number of false positives to the total number of positive
associations, or the percentage of findings drawn from the null
distribution at a given significance level (5). To compute the FDR,
we used an analytic method that estimates the number of false-
positive results by creating a null distribution of regression test
statistics; this was accomplished by randomly assigning both
the case status and time to event, running the Cox propor-
tional hazards model, and collecting the associated P value over
1000 permutations (6, 7). Foods/nutrients with a P value ,0.05
for the comparison of quartile 4 and quartile 1 of intake were
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selected for validation studies. Last, to increase the power and
provide a global estimate of the effect size, we computed overall
estimates for food/nutrient intake and EOC risk associations for
the EPIC study and the NLCS by combining coefficients from
each study by using random-effects meta-analysis. Cox pro-
portional hazards regression was performed by using the survival
(20) package and random-effects meta-analysis was performed by
using the metafor (21) and rmeta (22) packages in R (version
3.0.2; R Core Team) (23).
RESULTS
In total, 1522 incident invasive EOCs were evaluated, in-
cluding 1095 cases from the EPIC study, with a mean 6 SD
follow-up of 11.0 6 2.7 y, and 383 cases from the NLCS, with
a mean 6 SD subcohort follow-up of 15.6 6 3.7 y. In com-
parisons of the study population characteristics at baseline, we
observed that women in the NLCS subcohort were older (mean
age: 61.4 y for NLCS compared with 50.1 y for EPIC) and less
likely to ever use oral contraceptives (25% of NLCS participants
used oral contraceptives compared with 59% in the EPIC study)
(Table 1).
Of the 57 foods/nutrients that were evaluated in the EPIC
study, 4 were statistically significantly associated with EOC risk
(comparing quartile 4 and quartile 1) and had a FDR of 0.43
(Figure 1, Supplemental Table 1). In comparisons of partici-
pants who reported high with those who reported low dietary
intake, cholesterol, polyunsaturated fat, and saturated fat were
associated with a higher risk of EOC, whereas banana con-
sumption was associated with a lower risk of EOC. We ob-
served a dose-response for polyunsaturated fat intake (P-trend =
0.04) but not for cholesterol, saturated fat, or banana intake.
Heterogeneity across the EPIC countries for the 57 foods/
nutrients that were assessed was rare [P value for heteroge-
neity (P-heterogeneity) # 0.04 for calcium, retinol, wine, and
potatoes]; all analyses were therefore carried out in the entire
EPIC cohort. Apart from cholesterol, polyunsaturated and sat-
urated fat, and banana intake, the remaining foods and nutri-
ents that were assessed did not meet the statistical significance
cutoff (Supplemental Table 2).
In the NLCS, we then evaluated the 4 foods/nutrients that were
identified previously. Compared with the EPIC cohort, the NLCS
subcohort participants consumed on average higher amounts
of polyunsaturated and saturated fat and had a lower intake of
banana and total energy intake (Supplemental Table 3). None of
the 4 foods/nutrients were independently associated with EOC
risk in the NLCS (Supplemental Table 4); however, we ob-
served similar risk estimates when comparing participants with
the highest and lowest quartiles of saturated fat (1.22 and 1.19)
intake in the EPIC study and the NLCS, respectively, and meta-
analysis of these studies highlighted a statistically significant
positive association with saturated fat intake (quartile 4 com-
pared with quartile 1; overall HR: 1.21; 95% CI: 1.04, 1.41)
(Figure 2). Because all of the NLCS participants were post-
menopausal, we carried out a meta-analysis of postmenopausal
EPIC study participants and the NLCS and observed that the
suggestive positive association with saturated fat intake re-
mained (quartile 4 compared with quartile 1; overall HR: 1.18;
95% CI: 0.99, 1.41) (Supplemental Figure 2, Supplemental
Table 5).
Serous tumors accounted for 582 (53.2%) and 186 (48.6%) of
the EPIC and NLCS cases, respectively. In meta-analysis of
serous tumors in the EPIC study and the NLCS, we observed no
association with saturated fat intake (quartile 4 compared with
quartile 1; overall HR: 1.11; 95% CI: 0.86, 1.44) (Supplemental
Figure 3). Nonserous histologic subtypes of EOC were not
evaluated separately because of the small number of cases; for
example, there were 118 and 31 endometrioid EOC cases in the
EPIC and NLCS studies, respectively.
DISCUSSION
In the current study, we used a novel NWAS approach to
evaluate dietary intake amounts of 57 foods/food groups and
nutrients in the EPIC study and identified 4 dietary factors for
which the highest compared with the lowest intake amounts were
associated with a statistically significantly higher risk (choles-
terol, polyunsaturated fat, saturated fat) or lower risk (bananas) of
EOC. Using the criterion that a statistically significant association
in the same direction is required in the independent cohort
(NLCS) for validation, none of the dietary items were confirmed.
It has been suggested that a high intake of saturated and/or
animal fat or total fat may stimulate extraovarian estrogen
production (24), which may lead to an increased risk of
developing EOC (25). Our data were not consistent with this
hypothesis because in the EPIC study, there was no association
between animal and total fat intake when comparing participants
classified into the highest with those in the lowest quartiles of
intake with EOC risk. In contrast to reports of no association
between saturated fat intake and EOC risk in a pooled analysis of
12 cohorts (including the NLCS) (26) and the NIH-AARP study
(27), we observed a higher EOC risk with a high intake than with
a low intake of saturated fat. However, this finding is consistent
with our earlier report in the NLCS of a statistically significant
positive association with saturated fat intake on a continuous
scale and the nonsignificant higher risk of invasive EOC observed
when comparing the highest with the lowest quintiles of intake
(28). This study focused on fat and meat consumption and did
not use the NWAS method. Further studies are warranted first
to evaluate whether a high fat intake is associated with higher
TABLE 1
Age-standardized characteristics of the EPIC study and the NLCS1
EPIC NLCS2
Participants, n 325,004 2216
Age at enrollment, y 50.1 6 9.83 61.4 6 4.3
Parous, % 85 82
Ever use of OCs, % 59 25
Postmenopausal, % 45 100
Children,4 n 2.3 6 1.0 3.4 6 2.0
Duration of OC use,5 y 7.8 6 7.3 7.4 6 5.4
BMI, kg/m2 24.9 6 4.4 24.3 6 5.8
1All variables except age were age standardized in 5-y age groups
according to the age distribution of the study population. EPIC, European
Prospective Investigation into Cancer and Nutrition; NLCS, Netherlands
Cohort Study; OC, oral contraceptive.
2Values refer to the NLCS subcohort.
3Mean 6 SD (all such values).
4Among parous women.
5Among OC ever users.
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circulating endogenous estrogen concentrations because results
to support this mechanistic link have been inconsistent (29–31),
and it is possible that the reported significant associations may
be due to chance. Second, if the link between fat intake and
circulating estrogen concentrations is confirmed, it may be of
interest to investigate the association between fat intake and risk
of endometrioid EOC because a recent study of women during
pregnancy observed that higher estradiol concentrations were
associated with a higher risk to develop endometrioid but not
serous EOC (32). We were unable to evaluate endometrioid
tumors in the current study because of the small number of
cases. Of the other dietary factors that were investigated but not
confirmed in the current study, consumption of polyunsaturated
fat and cholesterol (26) and bananas (33) has been evaluated in
previous pooled analyses or meta-analyses of prospective cohort
studies, and consistent with our final conclusions, these nutrients
and foods did not appear to be associated with EOC risk.
Advantages of the NWAS approach were the ability to sys-
tematically evaluate an extensive list of dietary factors in relation
to EOC risk while accounting for multiple testing by estimating
the FDR, and by examining the associations between selected
foods/nutrients and EOC risk in the NLCS, this provided further
confidence in our findings. For most foods/nutrients that were
evaluated in the EPIC study, we observed no association with
EOC risk; this observation emphasizes the importance of the
NWAS method because it necessitates the reporting of all results
and therefore addresses the issue of the selective reporting of
statistically significant findings (34, 35). For example, it appears
that much of the published literature has reported findings where
the P value is ,0.05 (35). Possible limitations of this study
included the single assessment of diet at the study baseline and
the use of a self-reported dietary assessment, which could lead
to some amount of misclassification of dietary intake and may
attenuate the risk estimates toward the null. Thus, complementary
FIGURE 2 Forest plots showing multivariate HRs and 95% CIs for com-
parisons of the highest and lowest categories of intake of 4 foods and nutrients in
relation to epithelial ovarian cancer risk in the EPIC study and the NLCS. Foods
and nutrients were evaluated if they had a P value ,0.05 for the comparison of
extreme quartiles of dietary intake in the EPIC study based on results from
multivariate-adjusted Cox proportional hazards regression. Overall risk estimates
were estimated from random-effects meta-analysis. P-heterogeneity comparing the
EPIC study and the NLCS were $0.14 with the following exceptions: PUFAs
(P-heterogeneity = 0.01) and bananas (P-heterogeneity = 0.04). Multivariate
models were adjusted for total energy intake, oral contraceptive use, menopausal
status, and parity and were stratified by age (both studies) and study center (EPIC
only). Contrasts and median intake values were cholesterol (EPIC: quartile 4,
334.7 mg/d compared with quartile 1, 148.5 mg/d; NLCS: quartile 4,
292.3 mg/d compared with quartile 1, 164.1 mg/d), polyunsaturated fat (EPIC:
quartile 4, 14.5 g/d compared with quartile 1, 7.0 g/d; NLCS: quartile 4,
21.1 g/d compared with quartile 1, 7.9 g/d), saturated fat (EPIC: quartile 4,
29.6 g/d compared with quartile 1, 17.4 g/d; NLCS: quartile 4, 34.3 g/d com-
pared with quartile 1, 22.0 g/d), and bananas (EPIC: quartile 4, 62.4 g/d compared
with quartile 1, 0 g/d; NLCS: highest, 32.1 g/d compared with lowest, 0 g/d).
EPIC, European Prospective Investigation into Cancer and Nutrition; NLCS,
Netherlands Cohort Study.
FIGURE 1 “Manhattan plot” showing results from the nutrient-wide association study method to evaluate the association between dietary intake of
various foods and nutrients and epithelial ovarian cancer risk in the EPIC study. The y axis shows the 2log10 P values from the multivariate-adjusted Cox
proportional hazards regression coefficient for the comparison of the highest with the lowest quartiles of dietary intake (red horizontal line indicates P = 0.05).
Each x axis label represents a dietary category (for visualization purposes only; each dietary factor was analyzed one at a time), and within each category,
dietary items were ordered left to right according to the lowest to highest HR. The 4 dietary factors that were selected for confirmation in the NLCS were
labeled with the HR from the EPIC study for the comparison of the highest and the lowest quartiles of dietary intake in relation to risk of epithelial ovarian
cancer. EPIC, European Prospective Investigation into Cancer and Nutrition; NLCS, Netherlands Cohort Study.
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methods of dietary assessment such as biomarker studies would
be useful to corroborate the current results. In the NLCS co-
hort, we observed null results for the dietary factors that were
examined; this may be because of the smaller number of cases,
and/or limiting the validation study to a single national cohort
with typical dietary habits may introduce an element of chance
when validating dietary associations. It is also possible that
other participant characteristics, such as differences in die-
tary intake amounts, could explain why the dietary associa-
tions were not confirmed; thus, meta-analyses including a large
number of cohort studies would complement results from this
NWAS. Because we were unable to evaluate the less common
histologic subtypes of EOC because of the small numbers in
the current study, larger pooled studies or consortium efforts
are needed to investigate dietary risk associations for the rarer
histologic subtypes of EOC. Dietary associations for EOC may
also exist for specific foods/nutrients that were not included in
the current analysis. Finally, as with any observational study,
concern remains about residual confounding, even though we
controlled for parity, oral contraceptive use, and menopausal
status in the models.
In summary, these results represent the use of a novel NWAS
method to assist in the search for modifiable dietary risk factors
that may be of importance for the prevention of EOC. We
evaluated dietary intake of 57 foods/food groups and nutrients in
the EPIC study, and the 4 dietary factors that met the signifi-
cance threshold were investigated in the NLCS. In the combined
results from the EPIC study and the NLCS, we observed a higher
EOC risk with a high intake than with a low intake of saturated
fat, although there was no evidence of a dose-response relation.
The positive associations with high compared with low satu-
rated fat intake and risk of EOC observed in the EPIC study and
NLCS could be due to chance, and it remains to be determined
whether the association with saturated fat intake will be of
clinical importance. Additional studies are needed to confirm
the possible positive association between saturated fat intake
and EOC risk.
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